238 related articles for article (PubMed ID: 24630363)
1. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis.
Aggarwal T; Polanco MJ; Scaramuzzino C; Rocchi A; Milioto C; Emionite L; Ognio E; Sambataro F; Galbiati M; Poletti A; Pennuto M
Neurobiol Aging; 2014 Aug; 35(8):1929-38. PubMed ID: 24630363
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor antagonism accelerates disease onset in the SOD1
McLeod VM; Lau CL; Chiam MDF; Rupasinghe TW; Roessner U; Djouma E; Boon WC; Turner BJ
Br J Pharmacol; 2019 Jul; 176(13):2111-2130. PubMed ID: 30849180
[TBL] [Abstract][Full Text] [Related]
3. The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis.
Galbiati M; Onesto E; Zito A; Crippa V; Rusmini P; Mariotti R; Bentivoglio M; Bendotti C; Poletti A
Pharmacol Res; 2012 Feb; 65(2):221-30. PubMed ID: 22178654
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of disease onset, progression and sex differences from androgen receptor levels in a mouse model of amyotrophic lateral sclerosis.
Tomas D; McLeod VM; Chiam MDF; Wanniarachchillage N; Boon WC; Turner BJ
Sci Rep; 2021 Apr; 11(1):9255. PubMed ID: 33927243
[TBL] [Abstract][Full Text] [Related]
5. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.
Gertz B; Wong M; Martin LJ
J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
7. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
[TBL] [Abstract][Full Text] [Related]
8. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
9. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
11. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
12. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic.
Martin LJ; Adams DA; Niedzwiecki MV; Wong M
Cells; 2022 Oct; 11(21):. PubMed ID: 36359844
[TBL] [Abstract][Full Text] [Related]
14. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.
Knippenberg S; Sipos J; Thau-Habermann N; Körner S; Rath KJ; Dengler R; Petri S
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1052-61. PubMed ID: 24128678
[TBL] [Abstract][Full Text] [Related]
16. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
17. Mapping Motor Neuron Vulnerability in the Neuraxis of Male SOD1
McLeod VM; Chiam MDF; Perera ND; Lau CL; Boon WC; Turner BJ
Front Endocrinol (Lausanne); 2022; 13():808479. PubMed ID: 35273564
[TBL] [Abstract][Full Text] [Related]
18. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine alleviates ALS-like pathology in hSOD1
Lu J; He AX; Jin ZY; Zhang M; Li ZX; Zhou F; Ma L; Jin HM; Wang JY; Shen X
Acta Pharmacol Sin; 2024 May; 45(5):926-944. PubMed ID: 38286832
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
